XRTX: XORTX Therapeutics Company Aggregate Debts
The stable management of XORTX Therapeutics Inc. (XRTX) is renowned for its authority in developing therapies for degenerative pathologies. This price chart reflects debt dynamics, which currently stand at 0.00, while the business relies on external contractors for substance synthesis and testing. The team brings together immunologists and nephrologists dedicated to developing treatments for polycystic kidney disease.
%3A%20Company%20Debts&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_XRTX_-_XORTX-Therapeutics-Inc._-_Company-Debts "Aggregate Debt Obligations: XORTX (XRTX) for 07/04/2022 - 10/31/2026 | 👁️GURU.Markets👁️")
XORTX Therapeutics (XRTX) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization information:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital XORTX Therapeutics Inc|XRTX - Company Aggregate Debts|Debts to Net Assets XORTX|XRTX - Company Long-Term Debt|Company Current Liabilities XORTX Therapeutics|Quick Liquidity Indicator xortx.com
- earnings and valuation multiples information:
General company analysis:XRTX, XORTX Corp
This indicator reflects the total volume of borrowed funds and liabilities, determining the degree of financial leverage and the debt load of the enterprise. By analyzing the trend of total liabilities, an investor assesses the balance between capital expenditures and the solvency of XORTX Therapeutics Inc. (XRTX) during the development of innovative nephrology drugs, where a high density of borrowed capital often serves as a tool to accelerate clinical trials.
Competitors of XORTX Therapeutics Inc.
ARGX (argenx BVBA) - Aggregate Debt Obligations|Company Aggregate Debts BNTX (BioNTech SE)|Company Aggregate Debts Abivax Corp ABVX|ADMA - Company Debts|Aggregate Debt Obligations PTGX (Protagonist Therapeutics, Inc.)|Immunovant Corp (IMVT) - Company Debts|Company Total Debt Kiniksa Corp|GRFS (Grifols, S.A.) - Company Aggregate Debts|Company Aggregate Debts adaptivebiotech.com|Company Total Debt CLDX (Celldex Therapeutics, Inc.)|AUPH (Aurinia Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Aggregate Debts BCRX (BioCryst Pharmaceuticals Inc)|Company Total Debt Obligations Vera Corp (VERA)|DNTH - Company Debts|pharvaris.com (PHVS) - Company Total Debt|AbCellera Corp (ABCL) - Company Debts|Company Total Debt Tourmaline Bio Inc|Company Total Debt PGEN|Company Aggregate Debts Pharming Corp|Company Debts Nektar Therapeutics (NKTR)|upstreambio.com - Company Aggregate Debt|Company Aggregate Debts ZBIO (Zenas Biopharma)|Immunome Inc (IMNM) - Company Cumulative Debt|GOSS: Company Total Debt|KALV (KalVista Corp) - Company Aggregate Debt|Septerna Inc (SEPN) - Company Debts|Company Cumulative Debt pieris.com (PVLA)|Company Debts Savara|RIGL: Aggregate Debt Obligations|Company Total Debt ANAB (AnaptysBio Corp)|Company Cumulative Indebtedness ATXS|enGene Holdings Inc. - Company Total Debt|RAPT: Company Aggregate Debt|JBIO: Company Total Debt|Aggregate Debt Obligations ACRS (Aclaris Therapeutics Inc.)|KYTX (Kyverna) - Company Total Debt|TLSA: Company Cumulative Indebtedness|CABA (Cabaletta Bio, Inc.) - Company Aggregate Debts|VTYX: Aggregate Debt Obligations|Company Aggregate Debts THTX|AVTX - Company Cumulative Debt|Company Debts Eledon ELDN|Aggregate Debt Obligations AGEN|Climb Bio Inc - Company Aggregate Debts|ZURA - Company Aggregate Debts|aTyr Pharma (ATYR) - Company Debts|Company Aggregate Indebtedness ADAG (Adagene Inc.)|IMA (ImageneBio) - Company Aggregate Debts|Company Cumulative Debt Shattuck Therapeutics STTK|Company Total Debt EQ (Equillium, Inc.)|Company Aggregate Debts connectbiopharm.com (CNTB)|Immunic - Company Total Debt|Company Cumulative Indebtedness ATRA (Atara Biotherapeutics, Inc.)|InflaRx GmbH - Company Aggregate Debts|Company Total Debt Obligations X4 Pharmaceuticals, Inc XFOR|ACET: Company Aggregate Debts|Company Total Debt Celularity|Company Debts INmune Bio|Barinthus Biotherapeutics PLC (BRNS) - Company Total Debt Obligations|Company Total Debt KZR (Kezar Life Sciences, Inc)|SABS (SAB Biotherapeutics Inc) - Aggregate Debt Obligations|Company Aggregate Debts AKTX (Akari Therapeutics)|Company Total Debt Obligations Enlivex Therapeutics Ltd (ENLV)|QTTB - Company Debts|GOVX (GeoVax Labs) - Company Aggregate Debt|EDSA: Company Aggregate Debts|Company Total Debt iBio Corporation|Company Total Debt CARM|xtlbio.com (XTLB) - Company Total Debt Obligations|Company Total Debt BOLT (Bolt Biotherapeutics)|hcwbiologics.com - Company Aggregate Debt|Company Debts Aptevo Therapeutics Inc. APVO|Aggregate Debt Obligations AIM|ADTX: Company Total Debt|gribio.com - Company Cumulative Indebtedness|HIND (Vyome Holdings) - Company Total Debt|Company Aggregate Debt REVB|Company Debts Indaptus|BiondVax Pharmaceuticals - Company Aggregate Indebtedness|Company Aggregate Debts CALI|AFMD (affimed.com) - Aggregate Debt Obligations|Company Aggregate Debts ALLK (Allakos)|Company Aggregate Debts HOOKIPA Pharma, Inc. HOOK|IGMS - Company Debts|Aggregate Debt Obligations ITOS (iTeos Pharma)|Ocean Biomedical, Inc. (OCEA) - Company Debts|Company Total Debt tcbiopharm.com|THRD (Third Harmonic Bio, Inc.) - Company Aggregate Debts